{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:34:27Z","timestamp":1773801267145,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39239-3","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T09:34:15Z","timestamp":1771148055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential of non-specific blood biomarkers combined with EBV-specific antibodies for triaging in nasopharyngeal carcinoma screening"],"prefix":"10.1038","volume":"16","author":[{"given":"Chuxuan","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gengrong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"39239_CR1","doi-asserted-by":"crossref","unstructured":"Khoo, A. S. B. & Pua, K. C. Diagnosis and clinical evaluation of nasopharyngeal carcinoma. In Nasopharyngeal Carcinoma Vol. 778 (ed. Busson, P.) 1\u20139 (Springer New York, 2013).","DOI":"10.1007\/978-1-4614-5947-7_1"},{"key":"39239_CR2","doi-asserted-by":"publisher","first-page":"15497","DOI":"10.3390\/ijms160715497","volume":"16","author":"ZT Chen","year":"2015","unstructured":"Chen, Z. T., Liang, Z. G. & Zhu, X. D. A review: proteomics in nasopharyngeal carcinoma. Int. J. Mol. Sci. 16, 15497\u201315530 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"39239_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","volume":"374","author":"LL Tang","year":"2016","unstructured":"Tang, L. L. et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 374, 22\u201330 (2016).","journal-title":"Cancer Lett."},{"key":"39239_CR4","unstructured":"Clinical value and. Potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/36577966\/"},{"key":"39239_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ebiom.2018.02.019","volume":"30","author":"YQ He","year":"2018","unstructured":"He, Y. Q. et al. The relationship between environmental factors and the profile of Epstein-Barr virus antibodies in the lytic and latent infection periods in healthy populations from endemic and Non-Endemic nasopharyngeal carcinoma areas in China. EBioMedicine 30, 184\u2013191 (2018).","journal-title":"EBioMedicine"},{"key":"39239_CR6","first-page":"221","volume":"18","author":"W Kantakamalakul","year":"2000","unstructured":"Kantakamalakul, W. et al. Specific IgA antibody to Epstein-Barr viral capsid antigen: a better marker for screening nasopharyngeal carcinoma than EBV-DNA detection by polymerase chain reaction. Asian Pac. J. Allergy Immunol. 18, 221\u2013226 (2000).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"39239_CR7","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1158\/1078-0432.CCR-22-1600","volume":"28","author":"S Paudel","year":"2022","unstructured":"Paudel, S. et al. Serologic profiling using an Epstein-Barr virus mammalian expression library identifies EBNA1 IgA as a prediagnostic marker for nasopharyngeal carcinoma. Clin. Cancer Res. 28, 5221\u20135230 (2022).","journal-title":"Clin. Cancer Res."},{"key":"39239_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/sj.bjc.6603609","volume":"96","author":"MF Ji","year":"2007","unstructured":"Ji, M. F. et al. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br. J. Cancer. 96, 623\u2013630 (2007).","journal-title":"Br. J. Cancer"},{"key":"39239_CR9","doi-asserted-by":"publisher","first-page":"e19100","DOI":"10.1371\/journal.pone.0019100","volume":"6","author":"SM Cao","year":"2011","unstructured":"Cao, S. M. et al. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS One. 6, e19100 (2011).","journal-title":"PLoS One"},{"key":"39239_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.anl.2022.09.010","volume":"50","author":"M Lian","year":"2023","unstructured":"Lian, M. Combining Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma: A meta-analysis. Auris Nasus Larynx. 50, 430\u2013439 (2023).","journal-title":"Auris Nasus Larynx"},{"key":"39239_CR11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1186\/s12885-024-12878-3","volume":"24","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis. BMC Cancer. 24, 1115 (2024).","journal-title":"BMC Cancer"},{"key":"39239_CR12","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/ijc.33424","volume":"148","author":"GH Chen","year":"2021","unstructured":"Chen, G. H. et al. Prospective assessment of a nasopharyngeal carcinoma risk score in a population undergoing screening. Int. J. Cancer. 148, 2398\u20132406 (2021).","journal-title":"Int. J. Cancer"},{"key":"39239_CR13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","volume":"30","author":"ET Chang","year":"2021","unstructured":"Chang, E. T., Ye, W., Zeng, Y. X. & Adami, H. O. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 30, 1035\u20131047 (2021).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"39239_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/cam4.947","volume":"6","author":"XH Li","year":"2017","unstructured":"Li, X. H. et al. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study. Cancer Med. 6, 310\u2013319 (2017).","journal-title":"Cancer Med."},{"key":"39239_CR15","unstructured":"Prognostic Significance of Neutrophil to Lymphocyte Ratio. Lymphocyte to monocyte ratio, and platelet to lymphocyte ratio in patients with nasopharyngeal Carcinoma - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/28321405\/"},{"key":"39239_CR16","unstructured":"Elevated pretreatment platelet distribution. Width and platelet count predict poor prognosis in nasopharyngeal carcinoma - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/29285316\/"},{"key":"39239_CR17","doi-asserted-by":"publisher","first-page":"10375","DOI":"10.2147\/CMAR.S226050","volume":"11","author":"X Zhang","year":"2019","unstructured":"Zhang, X., Qin, Y. Y., Chen, M., Wu, Y. Y. & Lin, F. Q. Combined use of mean platelet Volume\/Platelet count ratio and platelet distribution width to distinguish between patients with nasopharyngeal Carcinoma, those with benign tumors of the Nasopharynx, and healthy subjects. Cancer Manag Res. 11, 10375\u201310382 (2019).","journal-title":"Cancer Manag Res."},{"key":"39239_CR18","unstructured":"Apolipoprotein, A-I. Is a prognosticator of nasopharyngeal carcinoma in the era of Intensity-modulated Radiotherapy - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/29556328\/"},{"key":"39239_CR19","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.2147\/CMAR.S197544","volume":"11","author":"J Lang","year":"2019","unstructured":"Lang, J., Hu, C., Lu, T., Pan, J. & Lin, T. Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives. Cancer Manag Res. 11, 6365\u20136376 (2019).","journal-title":"Cancer Manag Res."},{"key":"39239_CR20","unstructured":"A low albumin. To Globulin ratio with a high serum Globulin level is a prognostic marker for poor survival in cervical cancer patients treated with radiation based therapy - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/30640678\/"},{"key":"39239_CR21","unstructured":"Lt, Z. et al. [An elevated pretreatment serum Globulin level predicts a poor prognosis of nasopharyngeal carcinoma]. Nan Fang Yi Ke Da Xue Xue bao = J. South. Med. University 36, (2016)."},{"key":"39239_CR22","unstructured":"Carcinoembryonic antigen-related. Cell adhesion molecules (CEACAMs) in cancer progression and metastasis - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/23903773\/"},{"key":"39239_CR23","unstructured":"CEA levels in. patients with carcinoma of the esophagus - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/709520\/"},{"key":"39239_CR24","unstructured":"The impact of. The preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/27783149\/"},{"key":"39239_CR25","unstructured":"Lymphocyte percentage as. A valuable predictor of prognosis in lung cancer - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/35122390\/"},{"key":"39239_CR26","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1158\/1055-9965.EPI-13-1262","volume":"23","author":"C Ae","year":"2014","unstructured":"Ae, C. et al. Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan. Cancer Epidemiol. biomarkers & prevention: publication Am. Association Cancer Res. cosponsored Am. Soc. Prev. Oncology 23, 1213 (2014).","journal-title":"Cancer Epidemiol. biomarkers & prevention: publication Am. Association Cancer Res. cosponsored Am. Soc. Prev. Oncology"},{"key":"39239_CR27","unstructured":"High Levels of. Antibody that neutralize B-cell infection of Epstein-Barr virus and that bind EBV gp350 are associated with a lower risk of nasopharyngeal Carcinoma - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/26920891\/"},{"key":"39239_CR28","unstructured":"Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC). Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32614957\/"},{"key":"39239_CR29","unstructured":"Epstein-Barr virus antibodies. and the risk of associated malignancies: review of the literature - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/25167864\/"},{"key":"39239_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh, N. et al. Inflammation and cancer. Ann. Afr. Med. 18, 121\u2013126 (2019).","journal-title":"Ann. Afr. Med."},{"key":"39239_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser, K. E., Eichten, A. & Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer. 6, 24\u201337 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"39239_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12882-020-1707-1","volume":"21","author":"F Peng","year":"2020","unstructured":"Peng, F. et al. Albumin-globulin ratio and mortality in patients on peritoneal dialysis: a retrospective study. BMC Nephrol. 21, 51 (2020).","journal-title":"BMC Nephrol."},{"key":"39239_CR33","unstructured":"Low pretreatment serum. Globulin May predict favorable prognosis for gastric cancer patients - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/26476541\/"},{"key":"39239_CR34","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41598-023-27688-z","volume":"13","author":"YP Hsieh","year":"2023","unstructured":"Hsieh, Y. P., Tsai, S. M., Kor, C. T. & Chiu, P. F. Serum Globulin is a novel predictor of mortality in patients undergoing peritoneal Dialysis. Sci. Rep. 13, 1139 (2023).","journal-title":"Sci. Rep."},{"key":"39239_CR35","unstructured":"Clinical utility of external. Immunoscintigraphy with the IMMU-4 technetium-99m fab\u2019 antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/8708720\/"},{"key":"39239_CR36","unstructured":"Carcinoembryonic antigen for. Monitoring patients with small cell carcinoma of the lung during treatment - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/6254646\/"},{"key":"39239_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7150\/jca.16200","volume":"8","author":"H Fuellgraf","year":"2017","unstructured":"Fuellgraf, H. et al. The prognostic impact of the carcinoembryonic antigen in ampullary Cancer - A retrospective single center study. J. Cancer. 8, 657\u2013664 (2017).","journal-title":"J. Cancer"},{"key":"39239_CR38","unstructured":"Brief Communication Carcino-Embryonic Antigen (CEA)\u2026 Google Scholar. https:\/\/so1.typicalgame.com\/scholar?hl=en&q=Brief+Communication+Carcino-Embryonic+Antigen+%28CEA%29+in+Nasopharyngeal+Carcinoma+and+Chronic+Nasopharyngitis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39239-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:02:59Z","timestamp":1773788579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39239-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39239"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39239-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Zhongshan City People\u2019s Hospital Clinical Research and Animal Experiment Ethics Committee (No. 2024-080). Informed consent to participate was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"9164"}}